4
Changes in Ownership
Vericel Corp Filed Acc 0001593968-21-002569
Chief Medical Officer sold 15,881 shares at an average $40.11 ($636,930)
- Chief Medical Officer acquired 20,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hopper Jonathan Mark Chief Medical Officer | 2021-12-20 | Option exercise | +1,000 | $10.95 | $10,950 | 40,428 | D |
| Hopper Jonathan Mark Chief Medical Officer | 2021-12-20 | Sale | −1,000 | $40.00 | $40,000 | 39,428 | D |
| Hopper Jonathan Mark Chief Medical Officer | 2021-12-22 | Option exercise | +9,000 | $10.95 | $98,550 | 48,428 | D |
| Hopper Jonathan Mark Chief Medical Officer | 2021-12-22 | Sale | −9,000 | $40.14 | $361,238 | 39,428 | D |
| Hopper Jonathan Mark Chief Medical Officer | 2021-12-22 | Option exercise | +10,000 | $16.66 | $166,600 | 49,428 | D |
| Hopper Jonathan Mark Chief Medical Officer | 2021-12-22 | Sale | −5,881 | $40.08 | $235,692 | 43,547 | D |
| Derivatives | |||||||
| Hopper Jonathan Mark Chief Medical Officer | 2021-12-20 | Option exercise · Stock Option (right to buy) | −1,000 | 56,604 | D | ||
| Hopper Jonathan Mark Chief Medical Officer | 2021-12-22 | Option exercise · Stock Option (right to buy) | −9,000 | 47,604 | D | ||
| Hopper Jonathan Mark Chief Medical Officer | 2021-12-22 | Option exercise · Stock Option (right to buy) | −10,000 | 16,000 | D | ||
| Open-market sales · 15,881 sh · avg $40.11 · $636,930 | |||||||
Loading xslF345X03/primary_01.xml…